ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman

April 1, 1994

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988

Amazon Links To NCI Materials, A First For NIH Health Content.

July 14, 2000

California Cancer Research Program Seeks Non-Resident Survivor Reviewers.

May 25, 2001

PA Center To Receive Share Of State’s Tobacco Settlement.

September 7, 2001

NCAB Hung Up On removing $ 45 Million Limit For Core Grants

September 17, 1976